PD-L2, an important PD-1 ligand, could be regulated in multiple ways and serve an irreplaceable role during the tumour immune escape process, eventually triggering tumorigenesis and tumour progression in various human cancers, including HNSCC. This evidence concerns the gene PDCD1LG2 and neoplasm.